HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 86 filers reported holding HARPOON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,272,142 | -43.2% | 315,668 | -90.0% | 1.63% | -15.1% |
| Q2 2023 | $2,241,256 | -4.1% | 3,156,699 | 0.0% | 1.92% | -0.3% |
| Q1 2023 | $2,335,957 | +2.0% | 3,156,699 | 0.0% | 1.93% | +16.4% |
| Q4 2022 | $2,290,816 | -25.2% | 3,156,699 | 0.0% | 1.66% | -8.8% |
| Q3 2022 | $3,062,000 | -49.2% | 3,156,699 | 0.0% | 1.82% | -53.5% |
| Q2 2022 | $6,029,000 | -61.6% | 3,156,699 | 0.0% | 3.91% | -49.5% |
| Q1 2022 | $15,689,000 | -34.2% | 3,156,699 | 0.0% | 7.73% | -10.5% |
| Q4 2021 | $23,833,000 | -4.4% | 3,156,699 | 0.0% | 8.64% | +20.0% |
| Q3 2021 | $24,938,000 | +641.3% | 3,156,699 | 0.0% | 7.19% | +733.5% |
| Q2 2021 | $3,364,000 | -94.9% | 3,156,699 | 0.0% | 0.86% | -94.4% |
| Q1 2021 | $66,038,000 | +36.1% | 3,156,699 | +8.1% | 15.37% | +37.1% |
| Q4 2020 | $48,525,000 | -2.2% | 2,921,405 | 0.0% | 11.21% | -43.9% |
| Q3 2020 | $49,635,000 | +2.4% | 2,921,405 | 0.0% | 20.00% | +43.7% |
| Q2 2020 | $48,495,000 | +43.3% | 2,921,405 | 0.0% | 13.92% | +37.5% |
| Q1 2020 | $33,830,000 | -21.7% | 2,921,405 | 0.0% | 10.12% | +7.8% |
| Q4 2019 | $43,208,000 | +8.3% | 2,921,405 | 0.0% | 9.39% | -22.2% |
| Q3 2019 | $39,906,000 | +5.1% | 2,921,405 | 0.0% | 12.07% | +18.6% |
| Q2 2019 | $37,978,000 | +37.3% | 2,921,405 | 0.0% | 10.18% | +34.3% |
| Q1 2019 | $27,666,000 | – | 2,921,405 | – | 7.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |